PF-08032562 for Advanced Breast or Colorectal Cancer
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Recruiting
Phase 1
Interventional Study
Advanced Breast Cancer
Metastatic Breast Cancer (HR+/ HER2-)
Colorectal Cancer
Metastatic Colorectal Adenocarcinoma
Triple Negative Breast Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 260 (estimated)
- Sponsor
- Pfizer · Industry
Who this trial is looking for
This trial is looking for people with advanced or metastatic breast or colorectal cancer. Participants will take a study medication by mouth and may also receive other cancer treatments during the trial.
Are You a Good Fit for This Trial?
You may be able to join if
- I am 18 years of age or older
- I have advanced or metastatic breast cancer or colorectal cancer
- I have measurable disease
- I have an ECOG performance status of 0 or 1
You may not be able to join if
- I have an active cancer within the last 3 years
- I have known brain metastases needing steroids
- I have life-threatening complications from my cancer
- I have had prior radiation to more than 25% of my bone marrow
- I have uncontrolled hypertension
- I have kidney problems
- I have liver dysfunction
- I have a significant heart problem
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The purpose of this study is to learn about the safety and effects of the study medicine when given alone or together with other anti-cancer therapies. Anti-cancer therapy is a type of treatment to stop the growth of cancer. This study also aims to find the best amount of study medication.
This study is seeking participants that have advanced or metastatic breast cancer (BC), or advanced or metas…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* 18 years of age or older
* Advanced or metastatic cancer of the breast or colon Part 1A: metastatic or advanced breast cancer or colorectal cancer for which no standard therapy is available Part 1B: metastatic or advanced breast cancer with disease progression after at least 1…
Contacts